On June 9-11, 2021, this poster was on display at the virtual International Forum on Quality and Safety in Healthcare EUROPE.
What is the Objective of this Poster?
- Validate an end-to-end adverse drug event (ADE) detection system from the licensed software package Spark NLP for Healthcare (John Snow Labs, Inc)
- Assess results against known ADEs of angiotensin converting enzyme inhibitors (ACE-I; a drug class for treatment of renal failure, hypertension, and heart disease)
Register to view the poster now!